|
ERR - Darja Lavõgina, a fresh PhD at the University of Tartu, broke ground with a dissertation that brings new insight to developers of cancer-fighting medicine.The strategy is unique, providing a whole new direction to the development of protein kinase inhibitors, said Stefan Knapp, of the University of Oxford, reported ETV.
The 24-year-old Lavõgina researched a specific group of enzymes (proteins that catalyze chemical reactions) that can also lead to new revelations for diabetes and Alzheimer's disease.
"The results show that there is a group of chemicals that can be used to block certain protein kinases, by which we could cure numerous diseases," said Lavõgina.
Read more: http://news.err.ee/sci-tech/5b866c30-eea2-47a2-af4e-05f36919c757
|
